Prenatal Screening Tests in Ordu

Screening indicates a lower or higher chance of a condition. A higher-chance result does not prove that the baby is affected, and a lower-chance result does not exclude every condition. This distinction matters when interpreting both blood tests and ultrasound findings.

Diagnostic procedures such as chorionic villus sampling or amniocentesis may be considered. The genetic analysis performed on the collected sample is a separate choice. Every test has a defined scope and limitations; no single examination identifies all genetic and developmental conditions.

Testing decisions follow an informed discussion. You can explain what knowing a result means to you, concerns about uncertainty and your views on further investigation. Agreeing to screening does not mean agreeing in advance to every possible follow-up procedure.

In the first trimester, blood measurements can be combined with ultrasound findings such as nuchal translucency. The Turkish Ministry of Health’s antenatal guide highlights the 11–14-week period for first-trimester screening. The precise appointment date depends on gestational age and the requirements for the measurements.

If you first attend later, options are reconsidered for the current stage of pregnancy. Second-trimester serum screening may be appropriate. Rather than arranging several independent screens for the same purpose, choose a coherent approach that takes previous results into account.

Prenatal ultrasound has a separate role in assessing structural development. A lower-chance NIPT result does not remove the need for an anatomical ultrasound. Ultrasound planning and any necessary referrals are addressed during the Turkish guide’s 18–24-week assessment period.

NIPT examines cell-free DNA fragments in maternal blood that largely originate from the placenta. It is a strong screening option for common chromosome-number differences, but remains a screening test. It can generally be considered from 10 weeks, with suitability and scope clarified during counselling.

A larger panel does not necessarily provide additional benefit for every person. Routine population screening for rare microdeletions is not recommended. Discuss the conditions covered, limitations and possible uncertain results before giving the blood sample.

Twins, an early vanishing twin and some medical circumstances may affect test selection and interpretation. During multiple pregnancy follow-up, a singleton testing plan is not simply copied; the laboratory’s validated scope for that type of pregnancy matters.

A higher-chance result first requires review of the complete report. Gestational age, the condition identified and ultrasound findings are considered together. Fetal medicine or genetic counselling and suitable diagnostic tests may be discussed. Irreversible decisions should not be based on a screening result alone.

NIPT sometimes produces no reportable result. This is not equivalent to a lower-chance result. Depending on the reason, pregnancy stage and ultrasound findings, options may include another sample or diagnostic assessment. Repeating an inconclusive test without reviewing why it failed is not an adequate follow-up plan.

CVS samples the placenta, whereas amniocentesis samples fluid around the baby. Timing, the information available and possible risks, including miscarriage, are explained. If specialist referral is needed, the timing of that consultation should be planned.

Bring your last menstrual period date, the ultrasound report used to date the pregnancy, earlier screening reports and information about known genetic conditions in the family. Mention medicines and any fertility treatment used to conceive. The full report is more useful than a photograph of the line marked “high risk”.

If travelling from Korgan, Kumru or Ünye, confirm the dates and locations for blood sampling and ultrasound. Some screening windows are limited, so avoid leaving booking until the final day. Clarify how results will be communicated and whether a follow-up consultation is needed.

Screening does not replace blood pressure checks or other routine care. Pregnancy follow-up assesses maternal health alongside fetal development. Ask about preparation for blood sampling, including any other tests planned for the same day.

Prenatal screening in Ordu is most useful when appropriately timed and clearly explained. Understanding the test’s scope, continuing ultrasound follow-up and considering diagnostic assessment when needed support informed decisions.